CERo Therapeutics Holdings, Inc. is a blank check company, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
9
Frequently Asked Questions
What is Market Cap of CERo Therapeutics Holdings Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CERo Therapeutics Holdings Inc. market cap is $5.72M.
What is the 52-week high for CERo Therapeutics Holdings Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. CERo Therapeutics Holdings Inc. 52 week high is $12.80 as of June 16, 2024.
What is the 52-week low for CERo Therapeutics Holdings Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CERo Therapeutics Holdings Inc. 52 week low is $0.3301 as of June 16, 2024.
What is CERo Therapeutics Holdings Inc. stock price today?
CERo Therapeutics Holdings Inc. stock price today is $0.3799.
What was CERo Therapeutics Holdings Inc. stock price yesterday?
CERo Therapeutics Holdings Inc. stock price yesterday was $0.3596.
What is the PE ratio of CERo Therapeutics Holdings Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CERo Therapeutics Holdings Inc.’s P/E ratio is -0.82.
What is the Price-to-Book ratio of CERo Therapeutics Holdings Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CERo Therapeutics Holdings Inc. P/B ratio is -0.5118.
What is CERo Therapeutics Holdings Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. CERo Therapeutics Holdings Inc.'s EBITDA is -7.96.
What is the 50-day moving average of CERo Therapeutics Holdings Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CERo Therapeutics Holdings Inc. 50-day moving average is $1.23.
How many employess does CERo Therapeutics Holdings Inc. has?